Mesoblast (ASX:MSB) Announces U.S. Tariff Exemption for Allogeneic Cell Therapies
Mesoblast (ASX:MSB) announces its allogeneic cell therapies are exempt from U.S. tariffs as ‘U.S. Country of Origin’ products.
Tag: Industry-Specific News
Orthocell Limited (ASX:OCC) Receives FDA Clearance for Remplir™
Orthocell (ASX:OCC) secures FDA clearance for Remplir™, enabling entry into the US $1.6 billion nerve repair market.
Australian Rare Earths Limited (ASX:AR3) Confirms Uranium Intersections
Australian Rare Earths Limited (ASX:AR3) confirms uranium intersections in OV047, highlighting significant mineralisation potential and ongoing drilling efforts.
Argent Minerals Limited (ASX:ARD) Announces High-Grade Gold Assay Results
Argent Minerals (ASX:ARD) announces high-grade gold assay results, confirming significant gold mineralisation at Trunkey Creek Project.
Benz Mining Corp (ASX:BNZ) Unveils High-Grade Gold Discovery at Glenburgh
Benz Mining Corp (ASX:BNZ) announces a significant high-grade gold discovery at Glenburgh, validating its targeting model and expanding exploration potential.
Blackstone Minerals Limited (ASX:BSX) Unlocks High Grade Copper-Gold at Mankayan
Blackstone Minerals (ASX:BSX) reports significant copper-gold assay results from drillhole BRC-60, reinforcing the potential of its Mankayan project.
AusQuest Limited (ASX:AQD) Commences Major Drilling Program
AusQuest Limited (ASX:AQD) launches a ~7,000m drilling program at its Balladonia Project in WA to test multiple base metal targets.
Breville Group Limited (ASX:BRG) Announces Response to US Tariffs
Breville Group Limited (ASX:BRG) outlines strategies to mitigate the impact of new US tariffs, maintaining its FY25 EBIT growth guidance.
Green Technology Metals (ASX:GT1) Enhances Lithium Resources at Root Project
Green Technology Metals (ASX:GT1) reports a 38% increase in Root Project’s lithium resources, reinforcing its position in Ontario’s lithium market.
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.